Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Saeki, Y; Fraefel, C; Ichikawa, T; Breakefield, XO; Chiocca, EA
   Improved helper virus-free packaging system for HSV amplicon vectors usingan ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome
   MOLECULAR THERAPY
   
   Y. Saeki et al., "Improved helper virus-free packaging system for HSV amplicon vectors usingan ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome", MOL THER, 3(4), 2001, pp. 591-601
2. Lam, PYP; Breakefield, XO
   Potential of gene therapy for brain tumors
   HUMAN MOLECULAR GENETICS
   
   P.Y.P. Lam e X.O. Breakefield, "Potential of gene therapy for brain tumors", HUM MOL GEN, 10(7), 2001, pp. 777-787
3. Hedrich, K; Kann, M; Lanthaler, AJ; Dalski, A; Eskelson, C; Landt, F; Schwinger, E; Vieregge, P; Lang, AE; Breakefield, XO; Ozelius, LJ; Pramstaller, PP; Klein, C
   The importance of gene dosage studies: mutational analysis of the parkin gene in early-onset parkinsonism
   HUMAN MOLECULAR GENETICS
   
   K. Hedrich et al., "The importance of gene dosage studies: mutational analysis of the parkin gene in early-onset parkinsonism", HUM MOL GEN, 10(16), 2001, pp. 1649-1656
4. Spear, MA; Breakefield, XO; Beltzer, J; Schuback, D; Weissleder, R; Pardo, FS; Ladner, R
   Isolation, characterization, and recovery of small peptide phage display epitopes selected against viable malignant glioma cells
   CANCER GENE THERAPY
   
   M.A. Spear et al., "Isolation, characterization, and recovery of small peptide phage display epitopes selected against viable malignant glioma cells", CANC GENE T, 8(7), 2001, pp. 506-511
5. Breakefield, XO; Kamm, C; Hanson, PI
   TorsinA: Movement at many levels
   NEURON
   
   X.O. Breakefield et al., "TorsinA: Movement at many levels", NEURON, 31(1), 2001, pp. 9-12
6. Aboody, KS; Brown, A; Rainov, NG; Bower, KA; Liu, SX; Yang, W; Small, JE; Herrlinger, U; Ourednik, V; Black, PM; Breakefield, XO; Snyder, EY
   Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas (vol 97, pg 12846, 2000)
   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
   
   K.S. Aboody et al., "Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas (vol 97, pg 12846, 2000)", P NAS US, 98(2), 2001, pp. 777-777
7. Yoshimura, S; Takagi, Y; Harada, J; Teramoto, T; Thomas, SS; Waeber, C; Bakowska, JC; Breakefield, XO; Moskowitz, MA
   FGF-2 regulation of neurogenesis in adult hippocampus after brain injury
   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
   
   S. Yoshimura et al., "FGF-2 regulation of neurogenesis in adult hippocampus after brain injury", P NAS US, 98(10), 2001, pp. 5874-5879
8. Jacobs, A; Tjuvajev, JG; Dubrovin, M; Akhurst, T; Balatoni, J; Beattie, B; Joshi, R; Finn, R; Larson, SM; Herrlinger, U; Pechan, PA; Chiocca, EA; Breakefield, XO; Blasberg, RG
   Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo
   CANCER RESEARCH
   
   A. Jacobs et al., "Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo", CANCER RES, 61(7), 2001, pp. 2983-2995
9. Sharma, N; Hewett, J; Ozelius, LJ; Ramesh, V; McLean, PJ; Breakefield, XO; Hyman, BT
   A close association of torsinA and alpha-synuclein in Lewy bodies - A fluorescence resonance energy transfer study
   AMERICAN JOURNAL OF PATHOLOGY
   
   N. Sharma et al., "A close association of torsinA and alpha-synuclein in Lewy bodies - A fluorescence resonance energy transfer study", AM J PATH, 159(1), 2001, pp. 339-344
10. Sena-Esteves, M; Saeki, Y; Fraefel, C; Breakefield, XO
    HSV-1 amplicon vectors - Simplicity and versatility
    MOLECULAR THERAPY
    
    M. Sena-Esteves et al., "HSV-1 amplicon vectors - Simplicity and versatility", MOL THER, 2(1), 2000, pp. 9-15
11. Herrlinger, U; Woiciechowski, C; Sena-Esteves, M; Aboody, KS; Jacobs, AH; Rainov, NG; Snyder, EY; Breakefield, XO
    Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas
    MOLECULAR THERAPY
    
    U. Herrlinger et al., "Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas", MOL THER, 1(4), 2000, pp. 347-357
12. Lam, PYP; Breakefield, XO
    Hybrid vector designs to control the delivery, fate and expression of transgenes
    JOURNAL OF GENE MEDICINE
    
    P.Y.P. Lam e X.O. Breakefield, "Hybrid vector designs to control the delivery, fate and expression of transgenes", J GENE MED, 2(6), 2000, pp. 395-408
13. Aghi, M; Hochberg, F; Breakefield, XO
    Prodrug activation enzymes in cancer gene therapy
    JOURNAL OF GENE MEDICINE
    
    M. Aghi et al., "Prodrug activation enzymes in cancer gene therapy", J GENE MED, 2(3), 2000, pp. 148-164
14. Costantini, LC; Jacoby, DR; Wang, S; Fraefel, C; Breakefield, XO; Isacson, O
    Gene transfer to the nigrostriatal system by hybrid herpes simplex virus/adeno-associated virus amplicon vectors (vol 10, pg 2481, 1999)
    HUMAN GENE THERAPY
    
    L.C. Costantini et al., "Gene transfer to the nigrostriatal system by hybrid herpes simplex virus/adeno-associated virus amplicon vectors (vol 10, pg 2481, 1999)", HUM GENE TH, 11(6), 2000, pp. 981-981
15. Sena-Esteves, M; Camp, SM; Alroy, J; Breakefield, XO; Kaye, EM
    Correction of acid beta-galactosidase deficiency in GM(1) gangliosidosis human fibroblasts by retrovirus vector-mediated gene transfer: Higher efficiency of release and cross-correction by the murine enzyme
    HUMAN GENE THERAPY
    
    M. Sena-Esteves et al., "Correction of acid beta-galactosidase deficiency in GM(1) gangliosidosis human fibroblasts by retrovirus vector-mediated gene transfer: Higher efficiency of release and cross-correction by the murine enzyme", HUM GENE TH, 11(5), 2000, pp. 715-727
16. Herrlinger, U; Jacobs, A; Quinones, A; Woiciechowsky, C; Sena-Esteves, M; Rainov, NG; Fraefel, C; Breakefield, XO
    Helper virus-free herpes simplex virus type 1 amplicon vectors for granulocyte-macrophage colony-stimulating factor-enhanced vaccination therapy for experimental glioma
    HUMAN GENE THERAPY
    
    U. Herrlinger et al., "Helper virus-free herpes simplex virus type 1 amplicon vectors for granulocyte-macrophage colony-stimulating factor-enhanced vaccination therapy for experimental glioma", HUM GENE TH, 11(10), 2000, pp. 1429-1438
17. Costantini, LC; Bakowska, JC; Breakefield, XO; Isacson, O
    Gene therapy in the CNS
    GENE THERAPY
    
    L.C. Costantini et al., "Gene therapy in the CNS", GENE THER, 7(2), 2000, pp. 93-109
18. Schellingerhout, D; Rainov, NG; Breakefield, XO; Weissleder, R
    Quantitation of HSV mass distribution in a rodent brain tumor model
    GENE THERAPY
    
    D. Schellingerhout et al., "Quantitation of HSV mass distribution in a rodent brain tumor model", GENE THER, 7(19), 2000, pp. 1648-1655
19. Hewett, J; Gonzalez-Agosti, C; Slater, D; Ziefer, P; Li, S; Bergeron, D; Jacoby, DJ; Ozelius, LJ; Ramesh, V; Breakefield, XO
    Mutant torsinA, responsible for early-onset torsion dystonia, forms membrane inclusions in cultured neural cells
    HUMAN MOLECULAR GENETICS
    
    J. Hewett et al., "Mutant torsinA, responsible for early-onset torsion dystonia, forms membrane inclusions in cultured neural cells", HUM MOL GEN, 9(9), 2000, pp. 1403-1413
20. Klein, C; Pramstaller, PP; Kis, B; Page, CC; Kann, M; Leung, J; Woodward, H; Castellan, CC; Scherer, M; Vieregge, P; Breakefield, XO; Kramer, PL; Ozelius, LJ
    Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: Expanding the phenotype
    ANNALS OF NEUROLOGY
    
    C. Klein et al., "Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: Expanding the phenotype", ANN NEUROL, 48(1), 2000, pp. 65-71
21. Klein, C; Gurvich, N; Sena-Esteves, M; Bressman, S; Brin, MF; Ebersole, BJ; Fink, S; Forsgren, L; Friedman, J; Grimes, D; Holmgren, G; Kyllerman, M; Lang, AE; de Leon, D; Leung, J; Prioleau, C; Raymond, D; Sanner, G; Saunders-Pullman, R; Vieregge, P; Wahlstrom, J; Breakefield, XO; Kramer, PL; Ozelius, LJ; Sealfon, SC
    Evaluation of the role of the D2 dopamine receptor in myoclonus dystonia
    ANNALS OF NEUROLOGY
    
    C. Klein et al., "Evaluation of the role of the D2 dopamine receptor in myoclonus dystonia", ANN NEUROL, 47(3), 2000, pp. 369-373
22. Fraefel, C; Jacoby, DR; Breakefield, XO
    Herpes simplex virus type 1-based amplicon vector systems
    ADVANCES IN VIRUS RESEARCH, VOL 55
    
    C. Fraefel et al., "Herpes simplex virus type 1-based amplicon vector systems", ADV VIRUS R, 55, 2000, pp. 425-451
23. Friedman, JRL; Klein, C; Leung, J; Woodward, H; Ozelius, LJ; Breakefield, XO; Charness, ME
    The GAG deletion of the DYT1 gene is infrequent in musicians with focal dystonia
    NEUROLOGY
    
    J.R.L. Friedman et al., "The GAG deletion of the DYT1 gene is infrequent in musicians with focal dystonia", NEUROLOGY, 55(9), 2000, pp. 1417-1418
24. Klein, C; Kann, M; Kis, B; Pramstaller, PP; Breakefield, XO; Ozelius, LJ; Vieregge, P
    The genetics of dystonia
    NERVENARZT
    
    C. Klein et al., "The genetics of dystonia", NERVENARZT, 71(6), 2000, pp. 431-441
25. Aboody, KS; Brown, A; Rainov, NG; Bower, KA; Liu, SX; Yang, W; Small, JE; Herrlinger, U; Ourednik, V; Black, PM; Breakefield, XO; Snyder, EY
    Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    K.S. Aboody et al., "Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas", P NAS US, 97(23), 2000, pp. 12846-12851
26. Bearer, EL; Breakefield, XO; Schuback, D; Reese, TS; LaVail, JH
    Retrograde axonal transport of herpes simplex virus: Evidence for a singlemechanism and a role for tegument
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    E.L. Bearer et al., "Retrograde axonal transport of herpes simplex virus: Evidence for a singlemechanism and a role for tegument", P NAS US, 97(14), 2000, pp. 8146-8150
27. Klein, C; Schilling, K; Saunders-Pullman, RJ; Garrels, J; Breakefield, XO; Brin, MF; deLeon, D; Doheny, D; Fahn, S; Fink, JS; Forsgren, L; Friedman, J; Frucht, S; Harris, J; Holmgren, G; Kis, B; Kurlan, R; Kyllerman, M; Lang, AE; Leung, J; Raymond, D; Robishaw, JD; Sanner, G; Schwinger, E; Tabamo, RE; Tagliati, M; Vieregge, P; Wahlstrom, J; Wendt, KJ; Kramer, PL; Bressman, SB; Ozelius, LJ
    A major locus for myoclonus-dystonia maps to chromosome 7q in eight families
    AMERICAN JOURNAL OF HUMAN GENETICS
    
    C. Klein et al., "A major locus for myoclonus-dystonia maps to chromosome 7q in eight families", AM J HU GEN, 67(5), 2000, pp. 1314-1319
28. Herrlinger, U; Jacobs, A; Aghi, M; Schuback, DE; Breakefield, XO
    HSV-1 vectors for gene therapy of experimental CNS tumors
    GENE THERAPY OF CANCER: METHODS AND PROTOCOLS
    
    U. Herrlinger et al., "HSV-1 vectors for gene therapy of experimental CNS tumors", METH MOL M, 35, 2000, pp. 287-312
29. Pechan, PA; Herrlinger, U; Aghi, M; Jacobs, A; Breakefield, XO
    Combined HSV-1 recombinant and amplicon piggyback vectors: Replication-competent and defective forms, and therapeutic efficacy for experimental gliomas
    JOURNAL OF GENE MEDICINE
    
    P.A. Pechan et al., "Combined HSV-1 recombinant and amplicon piggyback vectors: Replication-competent and defective forms, and therapeutic efficacy for experimental gliomas", J GENE MED, 1(3), 1999, pp. 176-185
30. Rainov, NG; Ikeda, K; Qureshi, NH; Grover, S; Herrlinger, U; Pechan, P; Chiocca, EA; Breakefield, XO; Barnett, FH
    Intraarterial delivery of adenovirus vectors and liposome-DNA complexes toexperimental brain neoplasms
    HUMAN GENE THERAPY
    
    N.G. Rainov et al., "Intraarterial delivery of adenovirus vectors and liposome-DNA complexes toexperimental brain neoplasms", HUM GENE TH, 10(2), 1999, pp. 311-318
31. Costantini, LC; Jacoby, DR; Wang, S; Fraefel, C; Breakefield, XO; Isacson, O
    Gene transfer to the nigrostriatal system by hybrid herpes simplex virus/adeno-associated virus amplicon vectors
    HUMAN GENE THERAPY
    
    L.C. Costantini et al., "Gene transfer to the nigrostriatal system by hybrid herpes simplex virus/adeno-associated virus amplicon vectors", HUM GENE TH, 10(15), 1999, pp. 2481-2494
32. Barnett, FH; Rainov, NG; Ikeda, K; Schuback, DE; Elliott, P; Kramm, CM; Chase, M; Qureshi, NH; Harsh, G; Chiocca, EA; Breakefield, XO
    Selective delivery of herpes virus vectors to experimental brain tumors using RMP-7
    CANCER GENE THERAPY
    
    F.H. Barnett et al., "Selective delivery of herpes virus vectors to experimental brain tumors using RMP-7", CANC GENE T, 6(1), 1999, pp. 14-20
33. Ozelius, LJ; Page, CE; Klein, C; Hewett, JW; Mineta, M; Leung, J; Shalish, C; Bressman, SB; de Leon, D; Brin, MF; Fahn, S; Corey, DP; Breakefield, XO
    The TOR1A (DYT1) gene family and its role in early onset torsion dystonia
    GENOMICS
    
    L.J. Ozelius et al., "The TOR1A (DYT1) gene family and its role in early onset torsion dystonia", GENOMICS, 62(3), 1999, pp. 377-384
34. Derby, ML; Sena-Esteves, M; Breakefield, XO; Corey, DP
    Gene transfer into the mammalian inner ear using HSV-1 and vaccinia virus vectors
    HEARING RESEARCH
    
    M.L. Derby et al., "Gene transfer into the mammalian inner ear using HSV-1 and vaccinia virus vectors", HEARING RES, 134(1-2), 1999, pp. 1-8
35. Augood, SJ; Martin, DM; Ozelius, LJ; Breakefield, XO; Penney, JB; Standaert, DG
    Distribution of the mRNAs encoding torsinA and torsinB in the normal adulthuman brain
    ANNALS OF NEUROLOGY
    
    S.J. Augood et al., "Distribution of the mRNAs encoding torsinA and torsinB in the normal adulthuman brain", ANN NEUROL, 46(5), 1999, pp. 761-769
36. Kramer, PL; Mineta, M; Klein, C; Schilling, K; de Leon, D; Farlow, MR; Breakefield, XO; Bressman, SB; Dobyns, WB; Ozelius, LJ; Brashear, A
    Rapid-onset dystonia-parkinsonism: Linkage to chromosome 19q13
    ANNALS OF NEUROLOGY
    
    P.L. Kramer et al., "Rapid-onset dystonia-parkinsonism: Linkage to chromosome 19q13", ANN NEUROL, 46(2), 1999, pp. 176-182
37. Klein, C; Breakefield, XO; Ozelius, LJ
    Genetics of primary dystonia
    SEMINARS IN NEUROLOGY
    
    C. Klein et al., "Genetics of primary dystonia", SEM NEUROL, 19(3), 1999, pp. 271-280
38. Schuback, DE; Mulligan, EL; Sims, KB; Tivol, EA; Greenberg, BD; Chang, SF; Yang, SL; Mau, YC; Shen, CY; Ho, MS; Yang, NH; Butler, MG; Fink, S; Schwartz, CE; Berlin, F; Breakefield, XO; Murphy, DL; Hsu, YPP
    Screen for MAOA mutations in target human groups
    AMERICAN JOURNAL OF MEDICAL GENETICS
    
    D.E. Schuback et al., "Screen for MAOA mutations in target human groups", AM J MED G, 88(1), 1999, pp. 25-28
39. Klein, C; Page, CE; LeWitt, P; Gordon, MF; de Leon, D; Awaad, Y; Breakefield, XO; Brin, MF; Ozelius, LJ
    Genetic analysis of three patients with an 18p- syndrome and dystonia
    NEUROLOGY
    
    C. Klein et al., "Genetic analysis of three patients with an 18p- syndrome and dystonia", NEUROLOGY, 52(3), 1999, pp. 649-651
40. Klein, C; Brin, MF; Kramer, P; Sena-Esteves, M; de Leon, D; Doheny, D; Bressman, S; Fahn, S; Breakefield, XO; Ozelius, LJ
    Association of a missense change in the D2 dopamine receptor with myoclonus dystonia
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    C. Klein et al., "Association of a missense change in the D2 dopamine receptor with myoclonus dystonia", P NAS US, 96(9), 1999, pp. 5173-5176
41. Sena-Esteves, M; Saeki, Y; Camp, SM; Chiocca, EA; Breakefield, XO
    Single-step conversion of cells to retrovirus vector producers with herpessimplex virus-Epstein-Barr virus hybrid amplicons
    JOURNAL OF VIROLOGY
    
    M. Sena-Esteves et al., "Single-step conversion of cells to retrovirus vector producers with herpessimplex virus-Epstein-Barr virus hybrid amplicons", J VIROLOGY, 73(12), 1999, pp. 10426-10439
42. Aghi, M; Chou, TC; Suling, K; Breakefield, XO; Chiocca, EA
    Multimodal cancer treatment mediated by a replicating oncolytic virus thatdelivers the oxazaphosphorine/rat cytochrome P4502B1 and ganciclovir/herpes simplex virus thymidine kinase gene therapies
    CANCER RESEARCH
    
    M. Aghi et al., "Multimodal cancer treatment mediated by a replicating oncolytic virus thatdelivers the oxazaphosphorine/rat cytochrome P4502B1 and ganciclovir/herpes simplex virus thymidine kinase gene therapies", CANCER RES, 59(16), 1999, pp. 3861-3865
43. Bearer, EL; Schlief, ML; Breakefield, XO; Schuback, DE; Reese, TS; LaVail, JH
    Squid axoplasm supports the retrograde axonal transport of Herpes simplex virus
    BIOLOGICAL BULLETIN
    
    E.L. Bearer et al., "Squid axoplasm supports the retrograde axonal transport of Herpes simplex virus", BIOL B, 197(2), 1999, pp. 257-258
44. Klein, C; Vieregge, P; Hagenah, J; Sieberer, M; Doyle, E; Jacobs, H; Gasser, T; Breakefield, XO; Risch, NJ; Ozelius, LJ
    Search for the PARK3 founder haplotype in a large cohort of patients with Parkinson's disease from Northern Germany
    ANNALS OF HUMAN GENETICS
    
    C. Klein et al., "Search for the PARK3 founder haplotype in a large cohort of patients with Parkinson's disease from Northern Germany", ANN HUM GEN, 63, 1999, pp. 285-291
45. Aghi, M; Chou, TC; Breakefield, XO; Chiocca, EA
    Synergistic anticancer effects of ganciclovir thymidine kinase and 5-fluorocytosine cytosine deaminase gene therapies - Response
    JOURNAL OF THE NATIONAL CANCER INSTITUTE
    
    M. Aghi et al., "Synergistic anticancer effects of ganciclovir thymidine kinase and 5-fluorocytosine cytosine deaminase gene therapies - Response", J NAT CANC, 91(3), 1999, pp. 285-286
46. Aghi, M; Kramm, CM; Breakefield, XO
    Folylpolyglutamyl synthetase gene transfer and glioma antifolate sensitivity in culture and in vivo
    JOURNAL OF THE NATIONAL CANCER INSTITUTE
    
    M. Aghi et al., "Folylpolyglutamyl synthetase gene transfer and glioma antifolate sensitivity in culture and in vivo", J NAT CANC, 91(14), 1999, pp. 1233-1241
47. SPEAR MA; HERRLINGER U; RAINOV N; PECHAN P; WEISSLEDER R; BREAKEFIELD XO
    TARGETING GENE-THERAPY VECTORS TO CNS MALIGNANCIES
    Journal of neurovirology
    
    M.A. Spear et al., "TARGETING GENE-THERAPY VECTORS TO CNS MALIGNANCIES", Journal of neurovirology, 4(2), 1998, pp. 133-147
48. RAINOV NG; DOBBERSTEIN KU; SENAESTEVES M; HERRLINGER U; KRAMM CM; PHILPOT RM; HILTON J; CHIOCCA EA; BREAKEFIELD XO
    NEW PRODRUG ACTIVATION GENE-THERAPY FOR CANCER USING CYTOCHROME-P450 4B1 AND 2-AMINOANTHRACENE 4-IPOMEANOL/
    Human gene therapy
    
    N.G. Rainov et al., "NEW PRODRUG ACTIVATION GENE-THERAPY FOR CANCER USING CYTOCHROME-P450 4B1 AND 2-AMINOANTHRACENE 4-IPOMEANOL/", Human gene therapy, 9(9), 1998, pp. 1261-1273
49. Saeki, Y; Ichikawa, T; Saeki, A; Chiocca, EA; Tobler, K; Ackermann, M; Breakefield, XO; Fraefel, C
    Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: Rescue of replication-competent virus progeny and packaging of amplicon vectors
    HUMAN GENE THERAPY
    
    Y. Saeki et al., "Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: Rescue of replication-competent virus progeny and packaging of amplicon vectors", HUM GENE TH, 9(18), 1998, pp. 2787-2794
50. HERRLINGER U; KRAMM CM; ABOODYGUTERMAN KS; SILVER JS; IKEDA K; JOHNSTON KM; PECHAN PA; BARTH RF; FINKELSTEIN D; CHIOCCA EA; LOUIS DN; BREAKEFIELD XO
    PREEXISTING HERPES-SIMPLEX VIRUS-1 (HSV-1) IMMUNITY DECREASES, BUT DOES NOT ABOLISH, GENE-TRANSFER TO EXPERIMENTAL BRAIN-TUMORS BY A HSV-1 VECTOR
    Gene therapy
    
    U. Herrlinger et al., "PREEXISTING HERPES-SIMPLEX VIRUS-1 (HSV-1) IMMUNITY DECREASES, BUT DOES NOT ABOLISH, GENE-TRANSFER TO EXPERIMENTAL BRAIN-TUMORS BY A HSV-1 VECTOR", Gene therapy, 5(6), 1998, pp. 809-819
51. KLEIN C; BRIN MF; DELEON D; LIMBORSKA SA; IVANOVASMOLENSKAYA IA; BRESSMAN SB; FRIEDMAN A; MARKOVA ED; RISCH NJ; BREAKEFIELD XO; OZELIUS LJ
    DE-NOVO MUTATIONS (GAG DELETION) IN THE DYT1 GENE IN 2 NON-JEWISH PATIENTS WITH EARLY-ONSET DYSTONIA
    Human molecular genetics (Print)
    
    C. Klein et al., "DE-NOVO MUTATIONS (GAG DELETION) IN THE DYT1 GENE IN 2 NON-JEWISH PATIENTS WITH EARLY-ONSET DYSTONIA", Human molecular genetics (Print), 7(7), 1998, pp. 1133-1136
52. RAINOV NG; DOBBERSTEIN KU; HEIDECKE V; DORANT U; CHASE M; KRAMM CM; CHIOCCA EA; BREAKEFIELD XO
    LONG-TERM SURVIVAL IN A RODENT BRAIN-TUMOR MODEL BY BRADYKININ-ENHANCED INTRAARTERIAL DELIVERY OF A THERAPEUTIC HERPES-SIMPLEX VIRUS VECTOR
    Cancer gene therapy
    
    N.G. Rainov et al., "LONG-TERM SURVIVAL IN A RODENT BRAIN-TUMOR MODEL BY BRADYKININ-ENHANCED INTRAARTERIAL DELIVERY OF A THERAPEUTIC HERPES-SIMPLEX VIRUS VECTOR", Cancer gene therapy, 5(3), 1998, pp. 158-162
53. KLEIN C; VIEREGGE P; HEIDE W; KEMPER B; HAGEDORNGREIWE M; HAGENAH J; VOLLMER C; BREAKEFIELD XO; KOMPF D; OZELIUS L
    EXCLUSION OF CHROMOSOME REGIONS 6P12 AND 15Q11, BUT NOT CHROMOSOME REGION 7P11, IN A GERMAN FAMILY WITH AUTOSOMAL-DOMINANT CONGENITAL NYSTAGMUS
    Genomics (San Diego, Calif.)
    
    C. Klein et al., "EXCLUSION OF CHROMOSOME REGIONS 6P12 AND 15Q11, BUT NOT CHROMOSOME REGION 7P11, IN A GERMAN FAMILY WITH AUTOSOMAL-DOMINANT CONGENITAL NYSTAGMUS", Genomics (San Diego, Calif.), 54(1), 1998, pp. 176-177
54. KLEIN C; PRAMSTALLER PP; CASTELLAN CC; BREAKEFIELD XO; KRAMER PL; OZELIUS LJ
    CLINICAL AND GENETIC EVALUATION OF A FAMILY WITH A MIXED DYSTONIA PHENOTYPE FROM SOUTH TYROL
    Annals of neurology
    
    C. Klein et al., "CLINICAL AND GENETIC EVALUATION OF A FAMILY WITH A MIXED DYSTONIA PHENOTYPE FROM SOUTH TYROL", Annals of neurology, 44(3), 1998, pp. 394-398
55. AUGOOD SJ; PENNEY JB; FRIBERG IK; BREAKEFIELD XO; YOUNG AB; OZELIUS LJ; STANDAERT DG
    EXPRESSION OF THE EARLY-ONSET TORSION DYSTONIA GENE (DYT1) IN HUMAN BRAIN
    Annals of neurology
    
    S.J. Augood et al., "EXPRESSION OF THE EARLY-ONSET TORSION DYSTONIA GENE (DYT1) IN HUMAN BRAIN", Annals of neurology, 43(5), 1998, pp. 669-673
56. MURPHY DL; SIMS K; EISENHOFER G; GREENBERG BD; GEORGE T; BERLIN F; ZAMETKIN A; ERNST M; BREAKEFIELD XO
    ARE MAO-A DEFICIENCY STATES IN THE GENERAL-POPULATION AND IN PUTATIVEHIGH-RISK POPULATIONS HIGHLY UNCOMMON
    Journal of neural transmission. Supplementum
    
    D.L. Murphy et al., "ARE MAO-A DEFICIENCY STATES IN THE GENERAL-POPULATION AND IN PUTATIVEHIGH-RISK POPULATIONS HIGHLY UNCOMMON", Journal of neural transmission. Supplementum, (52), 1998, pp. 29-38
57. MOHR L; RAINOV N; MOHR U; BREAKEFIELD XO; WANDS JR
    THE USE OF RABBIT CYTOCHROME-P450 4B1 AS NEW PRODRUG ACTIVATOR FOR GENE-THERAPY OF HEPATOCELLULAR-CARCINOMA
    Hepatology
    
    L. Mohr et al., "THE USE OF RABBIT CYTOCHROME-P450 4B1 AS NEW PRODRUG ACTIVATOR FOR GENE-THERAPY OF HEPATOCELLULAR-CARCINOMA", Hepatology, 28(4), 1998, pp. 1425-1425
58. JACOBS A; TJUVAJEV JG; JOSHI R; HERRLINGER U; BALATONI J; FINN R; BREAKEFIELD XO; BLASBERG RG
    MONITORING HSV-1-TK AND LACZ GENE DELIVERY AND COEXPRESSION BY A REPLICATION-CONDITIONAL HSV-1 VECTOR IN 9L GLIOSARCOMA CELLS - IMPLICATIONS FOR THERAPEUTIC GENE IMAGING IN-VIVO
    The Journal of nuclear medicine
    
    A. Jacobs et al., "MONITORING HSV-1-TK AND LACZ GENE DELIVERY AND COEXPRESSION BY A REPLICATION-CONDITIONAL HSV-1 VECTOR IN 9L GLIOSARCOMA CELLS - IMPLICATIONS FOR THERAPEUTIC GENE IMAGING IN-VIVO", The Journal of nuclear medicine, 39(5), 1998, pp. 1042-1042
59. PRAMSTALLER PP; KLEIN C; CASTELLAN C; BREAKEFIELD XO; OZELIUS LJ
    CLINICAL AND GENETIC-CHARACTERIZATION OF A FAMILY FROM SOUTH TYROL (NORTHERN ITALY) WITH AN UNUSUAL PRESENTATION OF DYSTONIA
    Neurology
    
    P.P. Pramstaller et al., "CLINICAL AND GENETIC-CHARACTERIZATION OF A FAMILY FROM SOUTH TYROL (NORTHERN ITALY) WITH AN UNUSUAL PRESENTATION OF DYSTONIA", Neurology, 50(4), 1998, pp. 2027-2027
60. KLEIN C; VIEREGGE P; HAGENAH J; RISCH NJ; BREAKEFIELD XO; OZELIUS LJ
    A GENETIC-STUDY OF 72 PATIENTS WITH IDIOPATHIC FOCAL DYSTONIA FROM NORTHERN GERMANY
    Neurology
    
    C. Klein et al., "A GENETIC-STUDY OF 72 PATIENTS WITH IDIOPATHIC FOCAL DYSTONIA FROM NORTHERN GERMANY", Neurology, 50(4), 1998, pp. 2098-2098
61. OZELIUS LJ; KLEIN C; DELEON D; BREAKEFIELD XO; BRESSMAN SB
    A DE-NOVO MUTATION (GAG DELETION) IN THE DYT1 GENE IN A PATIENT OF MENNONITE ORIGIN
    Neurology
    
    L.J. Ozelius et al., "A DE-NOVO MUTATION (GAG DELETION) IN THE DYT1 GENE IN A PATIENT OF MENNONITE ORIGIN", Neurology, 50(4), 1998, pp. 2103-2103
62. JACOBS AH; TJUVAJEV JG; JOSHI A; JOSHI R; HERRLINGER U; BALATONI J; FINN R; BREAKEFIELD XO; BLASBERG RG
    QUANTITATIVE KINETICS OF HSV-1-TK GENE DELIVERY TO TUMOR-CELLS USING A RECOMBINANT HSV-1 VECTOR - IMPLICATIONS FOR IMAGING HSV-1 MEDIATED GENE-TRANSFER IN-VIVO
    Neurology
    
    A.H. Jacobs et al., "QUANTITATIVE KINETICS OF HSV-1-TK GENE DELIVERY TO TUMOR-CELLS USING A RECOMBINANT HSV-1 VECTOR - IMPLICATIONS FOR IMAGING HSV-1 MEDIATED GENE-TRANSFER IN-VIVO", Neurology, 50(4), 1998, pp. 5028-5028
63. FRAEFEL C; WINGROVE D; MOORE R; PESSAH IN; BREAKEFIELD XO; ALLEN PD
    HSV-1 VECTORS ALLOW EFFICIENT TRANSFER OF THE RYR1 CDNA INTO DYSPEDICSKELETAL-MUSCLE CELLS
    Biophysical journal
    
    C. Fraefel et al., "HSV-1 VECTORS ALLOW EFFICIENT TRANSFER OF THE RYR1 CDNA INTO DYSPEDICSKELETAL-MUSCLE CELLS", Biophysical journal, 74(2), 1998, pp. 142-142
64. Klein, C; Ozelius, LJ; Hagenah, J; Breakefield, XO; Risch, NJ; Vieregge, P
    Search for a founder mutation in idiopathic focal dystonia from northern Germany
    AMERICAN JOURNAL OF HUMAN GENETICS
    
    C. Klein et al., "Search for a founder mutation in idiopathic focal dystonia from northern Germany", AM J HU GEN, 63(6), 1998, pp. 1777-1782
65. AGHI M; KRAMM CM; CHOU TC; BREAKEFIELD XO; CHIOCCA EA
    SYNERGISTIC ANTICANCER EFFECTS OF GANCICLOVIR THYMIDINE KINASE AND 5-FLUOROCYTOSINE/CYTOSINE DEAMINASE GENE THERAPIES/
    Journal of the National Cancer Institute
    
    M. Aghi et al., "SYNERGISTIC ANTICANCER EFFECTS OF GANCICLOVIR THYMIDINE KINASE AND 5-FLUOROCYTOSINE/CYTOSINE DEAMINASE GENE THERAPIES/", Journal of the National Cancer Institute, 90(5), 1998, pp. 370-380
66. ISACSON O; BREAKEFIELD XO
    BENEFITS AND RISKS OF HOSTING ANIMAL-CELLS IN THE HUMAN BRAIN
    Nature medicine
    
    O. Isacson e X.O. Breakefield, "BENEFITS AND RISKS OF HOSTING ANIMAL-CELLS IN THE HUMAN BRAIN", Nature medicine, 3(9), 1997, pp. 964-969
67. FRAEFEL C; JACOBY DR; LAGE C; HILDERBRAND H; CHOU JY; ALT FW; BREAKEFIELD XO; MAJZOUB JA
    GENE-TRANSFER INTO HEPATOCYTES MEDIATED BY HELPER VIRUS-FREE HSV AAV HYBRID VECTORS/
    Molecular medicine
    
    C. Fraefel et al., "GENE-TRANSFER INTO HEPATOCYTES MEDIATED BY HELPER VIRUS-FREE HSV AAV HYBRID VECTORS/", Molecular medicine, 3(12), 1997, pp. 813-825
68. OZELIUS LJ; HEWETT JW; PAGE CE; BRESSMAN SB; KRAMER PL; SHALISH C; DELEON D; BRIN MF; RAYMOND D; COREY DP; FAHN S; RISCH NJ; BUCKLER AJ; GUSELLA JF; BREAKEFIELD XO
    THE EARLY-ONSET TORSION DYSTONIA GENE (DYT1) ENCODES AN ATP BINDING-PROTEIN
    Nature genetics
    
    L.J. Ozelius et al., "THE EARLY-ONSET TORSION DYSTONIA GENE (DYT1) ENCODES AN ATP BINDING-PROTEIN", Nature genetics, 17(1), 1997, pp. 40-48
69. OZELIUS LJ; HEWETT J; KRAMER P; BRESSMAN SB; SHALISH C; DELEON D; RUTTER M; RISCH N; BRIN MF; MARKOVA ED; LIMBORSKA SA; IVANOVASMOLENSKAYA IA; MCCORMICK MK; FAHN S; BUCKLER AJ; GUSELLA JF; BREAKEFIELD XO
    FINE LOCALIZATION OF THE TORSION DYSTONIA GENE (DYT1) ON HUMAN-CHROMOSOME 9Q34 - YAC MAP AND LINKAGE DISEQUILIBRIUM
    PCR methods and applications
    
    L.J. Ozelius et al., "FINE LOCALIZATION OF THE TORSION DYSTONIA GENE (DYT1) ON HUMAN-CHROMOSOME 9Q34 - YAC MAP AND LINKAGE DISEQUILIBRIUM", PCR methods and applications, 7(5), 1997, pp. 483-494
70. YU JS; BURWICK JA; DRANOFF G; BREAKEFIELD XO
    GENE-THERAPY FOR METASTATIC BRAIN-TUMORS BY VACCINATION WITH GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR-TRANSDUCED TUMOR-CELLS
    Human gene therapy
    
    J.S. Yu et al., "GENE-THERAPY FOR METASTATIC BRAIN-TUMORS BY VACCINATION WITH GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR-TRANSDUCED TUMOR-CELLS", Human gene therapy, 8(9), 1997, pp. 1065-1072
71. JOHNSTON KM; JACOBY D; PECHAN PA; FRAEFEL C; BORGHESANI P; SCHUBACK D; DUNN RJ; SMITH FI; BREAKEFIELD XO
    HSV AAV HYBRID AMPLICON VECTORS EXTEND TRANSGENE EXPRESSION IN HUMAN GLIOMA-CELLS/
    Human gene therapy
    
    K.M. Johnston et al., "HSV AAV HYBRID AMPLICON VECTORS EXTEND TRANSGENE EXPRESSION IN HUMAN GLIOMA-CELLS/", Human gene therapy, 8(3), 1997, pp. 359-370
72. KRAMM CM; CHASE M; HERRLINGER U; JACOBS A; PECHAN PA; RAINOV NG; SENAESTEVES M; AGHI M; BARNETT FH; CHIOCCA EA; BREAKEFIELD XO
    THERAPEUTIC EFFICIENCY AND SAFETY OF A 2ND-GENERATION REPLICATION-CONDITIONAL HSV1 VECTOR FOR BRAIN-TUMOR GENE-THERAPY
    Human gene therapy
    
    C.M. Kramm et al., "THERAPEUTIC EFFICIENCY AND SAFETY OF A 2ND-GENERATION REPLICATION-CONDITIONAL HSV1 VECTOR FOR BRAIN-TUMOR GENE-THERAPY", Human gene therapy, 8(17), 1997, pp. 2057-2068
73. JACOBY DR; FRAEFEL C; BREAKEFIELD XO
    HYBRID VECTORS - A NEW-GENERATION OF VIRUS-BASED VECTORS DESIGNED TO CONTROL THE CELLULAR FATE OF DELIVERED GENES
    Gene therapy
    
    D.R. Jacoby et al., "HYBRID VECTORS - A NEW-GENERATION OF VIRUS-BASED VECTORS DESIGNED TO CONTROL THE CELLULAR FATE OF DELIVERED GENES", Gene therapy, 4(12), 1997, pp. 1281-1283
74. ABOODYGUTERMAN KS; PECHAN PA; RAINOV NG; SENAESTEVES M; JACOBS A; SNYDER EY; WILD P; SCHRANER E; TOBLER K; BREAKEFIELD XO; FRAEFEL C
    GREEN FLUORESCENT PROTEIN AS A REPORTER FOR RETROVIRUS AND HELPER VIRUS-FREE HSV-1 AMPLICON VECTOR-MEDIATED GENE-TRANSFER INTO NEURAL CELLSIN CULTURE AND IN-VIVO
    NeuroReport
    
    K.S. Aboodyguterman et al., "GREEN FLUORESCENT PROTEIN AS A REPORTER FOR RETROVIRUS AND HELPER VIRUS-FREE HSV-1 AMPLICON VECTOR-MEDIATED GENE-TRANSFER INTO NEURAL CELLSIN CULTURE AND IN-VIVO", NeuroReport, 8(17), 1997, pp. 3801-3808
75. HERRLINGER U; KRAMM CM; JOHNSTON KM; LOUIS DN; FINKELSTEIN D; REZNIKOFF G; DRANOFF G; BREAKEFIELD XO; YU JS
    VACCINATION FOR EXPERIMENTAL GLIOMAS USING GM-CSF-TRANSDUCED GLIOMA-CELLS
    Cancer gene therapy
    
    U. Herrlinger et al., "VACCINATION FOR EXPERIMENTAL GLIOMAS USING GM-CSF-TRANSDUCED GLIOMA-CELLS", Cancer gene therapy, 4(6), 1997, pp. 345-352
76. RAINOV NG; SENAESTEVES M; FRAEFEL C; DOBBERSTEIN KU; CHIOCCA EA; BREAKEFIELD XO
    A CHIMERIC FUSION PROTEIN OF CYTOCHROME CYP4B1 AND GREEN FLUORESCENT PROTEIN FOR DETECTION OF GENE-TRANSFER IN MALIGNANT GLIOMA
    Cancer gene therapy
    
    N.G. Rainov et al., "A CHIMERIC FUSION PROTEIN OF CYTOCHROME CYP4B1 AND GREEN FLUORESCENT PROTEIN FOR DETECTION OF GENE-TRANSFER IN MALIGNANT GLIOMA", Cancer gene therapy, 4(5), 1997, pp. 323-323
77. KAYE EM; SHALISH C; LIVERMORE J; TAYLOR HA; STEVENSON RE; BREAKEFIELD XO
    BETA-GALACTOSIDASE GENE-MUTATIONS IN PATIENTS WITH SLOWLY PROGRESSIVEG(M1) GANGLIOSIDOSIS
    Journal of child neurology
    
    E.M. Kaye et al., "BETA-GALACTOSIDASE GENE-MUTATIONS IN PATIENTS WITH SLOWLY PROGRESSIVEG(M1) GANGLIOSIDOSIS", Journal of child neurology, 12(4), 1997, pp. 242-247
78. SPEAR MA; SAKAMOTO KM; HERRLINGER U; PECHAN P; BREAKEFIELD XO
    FUNCTION OF THE EGR-1 T1S8 RADIATION INDUCIBLE PROMOTER IN A MINIMAL HSV-1 AMPLICON SYSTEM/
    International journal of radiation oncology, biology, physics
    
    M.A. Spear et al., "FUNCTION OF THE EGR-1 T1S8 RADIATION INDUCIBLE PROMOTER IN A MINIMAL HSV-1 AMPLICON SYSTEM/", International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 250-250
79. BRESSMAN SB; DELEON D; RAYMOND D; GREENE PE; BRIN MF; FAHN S; OZELIUS LJ; BREAKEFIELD XO; KRAMER PL; RISCH NJ
    SECONDARY DYSTONIA AND THE DYTI GENE
    Neurology
    
    S.B. Bressman et al., "SECONDARY DYSTONIA AND THE DYTI GENE", Neurology, 48(6), 1997, pp. 1571-1577
80. RAGE F; HILL DF; SENAESTEVES M; BREAKEFIELD XO; COFFEY RJ; COSTA ME; MCCANN SM; OJEDA SR
    TARGETING TRANSFORMING GROWTH-FACTOR-ALPHA EXPRESSION TO DISCRETE LOCI OF THE NEUROENDOCRINE BRAIN INDUCES FEMALE SEXUAL PRECOCITY
    Proceedings of the National Academy of Sciences of the United Statesof America
    
    F. Rage et al., "TARGETING TRANSFORMING GROWTH-FACTOR-ALPHA EXPRESSION TO DISCRETE LOCI OF THE NEUROENDOCRINE BRAIN INDUCES FEMALE SEXUAL PRECOCITY", Proceedings of the National Academy of Sciences of the United Statesof America, 94(6), 1997, pp. 2735-2740
81. PAULUS W; BAUR I; OBERER DM; BREAKEFIELD XO; REEVES SA
    REGULATED EXPRESSION OF THE DIPHTHERIA-TOXIN-A GENE IN HUMAN GLIOMA-CELLS USING PROKARYOTIC TRANSCRIPTIONAL CONTROL ELEMENTS
    Journal of neurosurgery
    
    W. Paulus et al., "REGULATED EXPRESSION OF THE DIPHTHERIA-TOXIN-A GENE IN HUMAN GLIOMA-CELLS USING PROKARYOTIC TRANSCRIPTIONAL CONTROL ELEMENTS", Journal of neurosurgery, 87(1), 1997, pp. 89-95
82. ZIMMER C; WRIGHT SC; ENGELHARDT RT; JOHNSON GA; KRAMM C; BREAKEFIELD XO; WEISSLEDER R
    TUMOR-CELL ENDOCYTOSIS IMAGING FACILITATES DELINEATION OF THE GLIOMA-BRAIN INTERFACE
    Experimental neurology
    
    C. Zimmer et al., "TUMOR-CELL ENDOCYTOSIS IMAGING FACILITATES DELINEATION OF THE GLIOMA-BRAIN INTERFACE", Experimental neurology, 143(1), 1997, pp. 61-69
83. OZELIUS LJ; HEWETT JW; SHALISH C; PAGE CE; BRESSMAN SB; KRAMER PL; DELEON D; BUCKLER AJ; BRIN MF; COREY DP; FAHN S; RISCH NJ; GUSELLA JF; BREAKEFIELD XO
    EARLY-ONSET TORSION DYSTONIA GENE (DYT1) ENCODES AN ATP-BINDING PROTEIN
    American journal of human genetics
    
    L.J. Ozelius et al., "EARLY-ONSET TORSION DYSTONIA GENE (DYT1) ENCODES AN ATP-BINDING PROTEIN", American journal of human genetics, 61(4), 1997, pp. 46-46
84. KRAMM CM; RAINOV NG; SENAESTEVES M; CHASE M; PECHAN PA; CHIOCCA EA; BREAKEFIELD XO
    HERPES VECTOR-MEDIATED DELIVERY OF MARKER GENES TO DISSEMINATED CENTRAL-NERVOUS-SYSTEM TUMORS
    Human gene therapy
    
    C.M. Kramm et al., "HERPES VECTOR-MEDIATED DELIVERY OF MARKER GENES TO DISSEMINATED CENTRAL-NERVOUS-SYSTEM TUMORS", Human gene therapy, 7(3), 1996, pp. 291-300
85. KRAMM CM; RAINOV NG; SENAESTEVES M; BARNETT FH; CHASE M; HERRLINGER U; PECHAN PA; CHIOCCA EA; BREAKEFIELD XO
    LONG-TERM SURVIVAL IN A RODENT MODEL OF DISSEMINATED BRAIN-TUMORS BY COMBINED INTRATHECAL DELIVERY OF HERPES VECTORS AND GANCICLOVIR TREATMENT
    Human gene therapy
    
    C.M. Kramm et al., "LONG-TERM SURVIVAL IN A RODENT MODEL OF DISSEMINATED BRAIN-TUMORS BY COMBINED INTRATHECAL DELIVERY OF HERPES VECTORS AND GANCICLOVIR TREATMENT", Human gene therapy, 7(16), 1996, pp. 1989-1994
86. PECHAN PA; FOTAKI M; THOMPSON RL; DUNN R; CHASE M; CHIOCCA EA; BREAKEFIELD XO
    A NOVEL PIGGYBACK PACKAGING SYSTEM FOR HERPES-SIMPLEX VIRUS AMPLICON VECTORS
    Human gene therapy
    
    P.A. Pechan et al., "A NOVEL PIGGYBACK PACKAGING SYSTEM FOR HERPES-SIMPLEX VIRUS AMPLICON VECTORS", Human gene therapy, 7(16), 1996, pp. 2003-2013
87. BATTINELLI EM; BOYD Y; CRAIG IW; BREAKEFIELD XO; CHEN ZY
    CHARACTERIZATION AND MAPPING OF THE MOUSE NDP (NORRIE DISEASE) LOCUS (NDP)
    Mammalian genome
    
    E.M. Battinelli et al., "CHARACTERIZATION AND MAPPING OF THE MOUSE NDP (NORRIE DISEASE) LOCUS (NDP)", Mammalian genome, 7(2), 1996, pp. 93-97
88. RAINOV NG; KRAMM CM; ABOODYGUTERMAN K; CHASE M; UEKI K; LOUIS DN; HARSH GR; CHIOCCA A; BREAKEFIELD XO
    RETROVIRUS-MEDIATED GENE-THERAPY OF EXPERIMENTAL BRAIN NEOPLASMS USING THE HERPES-SIMPLEX VIRUUS THYMIDINE KINASE GANCICLOVIR PARADIGM
    Cancer gene therapy
    
    N.G. Rainov et al., "RETROVIRUS-MEDIATED GENE-THERAPY OF EXPERIMENTAL BRAIN NEOPLASMS USING THE HERPES-SIMPLEX VIRUUS THYMIDINE KINASE GANCICLOVIR PARADIGM", Cancer gene therapy, 3(2), 1996, pp. 99-106
89. GASSER T; BOVE CM; OZELIUS LJ; HALLETT M; CHARNESS ME; HOCHBERG FH; BREAKEFIELD XO
    HAPLOTYPE ANALYSIS AT THE DYT1 LOCUS IN ASHKENAZI JEWISH PATIENTS WITH OCCUPATIONAL HAND DYSTONIA
    Movement disorders
    
    T. Gasser et al., "HAPLOTYPE ANALYSIS AT THE DYT1 LOCUS IN ASHKENAZI JEWISH PATIENTS WITH OCCUPATIONAL HAND DYSTONIA", Movement disorders, 11(2), 1996, pp. 163-166
90. DAVAR G; SHALISH C; BLUMENFELD A; BREAKEFIELD XO
    EXCLUSION OF P75(NGFR) AND OTHER CANDIDATE GENES IN A FAMILY WITH HEREDITARY SENSORY NEUROPATHY TYPE-II
    Pain
    
    G. Davar et al., "EXCLUSION OF P75(NGFR) AND OTHER CANDIDATE GENES IN A FAMILY WITH HEREDITARY SENSORY NEUROPATHY TYPE-II", Pain, 67(1), 1996, pp. 135-139
91. TIVOL EA; SHALISH C; SCHUBACK DE; HSU YP; BREAKEFIELD XO
    MUTATIONAL ANALYSIS OF THE HUMAN MAOA GENE
    American journal of medical genetics
    
    E.A. Tivol et al., "MUTATIONAL ANALYSIS OF THE HUMAN MAOA GENE", American journal of medical genetics, 67(1), 1996, pp. 92-97
92. INZELBERG R; OZELIUS LJ; BREAKEFIELD XO; KORCZYN AD
    A GENETIC-STUDY OF IDIOPATHIC TORSION DYSTONIA IN ISRAEL
    Neurology
    
    R. Inzelberg et al., "A GENETIC-STUDY OF IDIOPATHIC TORSION DYSTONIA IN ISRAEL", Neurology, 46(2), 1996, pp. 2008-2008
93. PAULUS W; BAUR I; BOYCE FM; BREAKEFIELD XO; REEVES SA
    SELF-CONTAINED, TETRACYCLINE-REGULATED RETROVIRAL VECTOR SYSTEM FOR GENE DELIVERY TO MAMMALIAN-CELLS
    Journal of virology
    
    W. Paulus et al., "SELF-CONTAINED, TETRACYCLINE-REGULATED RETROVIRAL VECTOR SYSTEM FOR GENE DELIVERY TO MAMMALIAN-CELLS", Journal of virology, 70(1), 1996, pp. 62-67
94. YU JS; ESTEVES MS; BREAKEFIELD XO; REEVES S
    GENE-THERAPY FOR BRAIN-TUMORS BY CONTROLLED EXPRESSION OF INTERLEUKIN-1-BETA-CONVERTING ENZYME
    Journal of neurosurgery
    
    J.S. Yu et al., "GENE-THERAPY FOR BRAIN-TUMORS BY CONTROLLED EXPRESSION OF INTERLEUKIN-1-BETA-CONVERTING ENZYME", Journal of neurosurgery, 84(2), 1996, pp. 718-718
95. NEUWELT EA; NILAVER G; MULDOON LL; KROLL RA; PAGEL MA; BREAKEFIELD XO; DAVIDSON BL
    DELIVERY OF HERPESVIRUS AND ADENOVIRUS TO NUDE RAT INTRACEREBRAL TUMORS FOLLOWING OSMOTIC BLOOD-BRAIN-BARRIER DISRUPTION
    Journal of neurosurgery
    
    E.A. Neuwelt et al., "DELIVERY OF HERPESVIRUS AND ADENOVIRUS TO NUDE RAT INTRACEREBRAL TUMORS FOLLOWING OSMOTIC BLOOD-BRAIN-BARRIER DISRUPTION", Journal of neurosurgery, 84(2), 1996, pp. 740-740
96. YU JS; SENAESTEVES M; PAULUS W; BREAKEFIELD XO; REEVES SA
    RETROVIRAL DELIVERY AND TETRACYCLINE-DEPENDENT EXPRESSION OF IL-1-BETA-CONVERTING ENZYME (ICE) IN A RAT GLIOMA MODEL PROVIDES CONTROLLED INDUCTION OF APOPTOTIC DEATH IN TUMOR-CELLS
    Cancer research
    
    J.S. Yu et al., "RETROVIRAL DELIVERY AND TETRACYCLINE-DEPENDENT EXPRESSION OF IL-1-BETA-CONVERTING ENZYME (ICE) IN A RAT GLIOMA MODEL PROVIDES CONTROLLED INDUCTION OF APOPTOTIC DEATH IN TUMOR-CELLS", Cancer research, 56(23), 1996, pp. 5423-5427
97. WEI MX; TAMIYA T; RHEE RJ; BREAKEFIELD XO; CHIOCCA EA
    DIFFUSIBLE CYTOTOXIC METABOLITES CONTRIBUTE TO THE IN-VITRO BYSTANDEREFFECT ASSOCIATED WITH THE CYCLOPHOSPHAMIDE CYTOCHROME-P450 2B1 CANCER GENE-THERAPY PARADIGM
    Clinical cancer research
    
    M.X. Wei et al., "DIFFUSIBLE CYTOTOXIC METABOLITES CONTRIBUTE TO THE IN-VITRO BYSTANDEREFFECT ASSOCIATED WITH THE CYCLOPHOSPHAMIDE CYTOCHROME-P450 2B1 CANCER GENE-THERAPY PARADIGM", Clinical cancer research, 1(10), 1995, pp. 1171-1177
98. SCHUBACK DE; CHEN ZY; CRAIG IW; BREAKEFIELD XO; SIMS KB
    MUTATIONS IN THE NORRIE DISEASE GENE
    Human mutation
    
    D.E. Schuback et al., "MUTATIONS IN THE NORRIE DISEASE GENE", Human mutation, 5(4), 1995, pp. 285-292
99. RAINOV NG; ZIMMER C; CHASE M; KRAMM CM; CHIOCCA EA; WEISSLEDER R; BREAKEFIELD XO
    SELECTIVE UPTAKE OF VIRAL AND MONOCRYSTALLINE PARTICLES DELIVERED INTRAARTERIALLY TO EXPERIMENTAL BRAIN NEOPLASMS
    Human gene therapy
    
    N.G. Rainov et al., "SELECTIVE UPTAKE OF VIRAL AND MONOCRYSTALLINE PARTICLES DELIVERED INTRAARTERIALLY TO EXPERIMENTAL BRAIN NEOPLASMS", Human gene therapy, 6(12), 1995, pp. 1543-1552
100. KRAMM CM; SENAESTEVES M; BARNETT FH; RAINOV NG; SCHUBACK DE; YU JS; PECHAN PA; PAULUS W; CHIOCCA EA; BREAKEFIELD XO
     GENE-THERAPY FOR BRAIN-TUMORS
     Brain pathology
     
     C.M. Kramm et al., "GENE-THERAPY FOR BRAIN-TUMORS", Brain pathology, 5(4), 1995, pp. 345-381